The Active Pharmaceutical Ingredient (API) portfolio is a core Strategic Business Unit. High quality standards and transparency in the manufacturing process make Unichem one of the most quality driven API manufacturing companies in the world.

Unichem offers a broad portfolio of APIs across various therapeutic areas. A strategic focus on new and complex APIs has led to more than 70 USDMFs (Drug Master Files) and 30 CEPs (Certificates of Suitability) being filed. Three state-of-the-art manufacturing sites across India provide a collective capacity of almost 600 KL.